Fingerprint
Dive into the research topics where Suleiman Mohammad Al-Hammadi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Chronic granulomatous disease in the United Arab Emirates: clinical and molecular characteristics in a single center
Al Kuwaiti, A. A., Al Dhaheri, A. D., Al Hassani, M., Ruszczak, Z., Alrustamani, A., Abuhammour, W., El Ghazali, G., Al-Hammadi, S. & Shendi, H. M., 2023, In: Frontiers in immunology. 14, 1228161.Research output: Contribution to journal › Article › peer-review
4 Link opens in a new tab Citations (Scopus) -
Epidemiology of combined immunodeficiencies affecting cellular and humoral immunity– a multicentric retrospective cohort study from the Arabian Peninsula
Al-Herz, W., Ziyab, A. H., Adeli, M., Al Farsi, T., Al-Hammadi, S., Al Kuwaiti, A. A., Al-Nesf, M., Al Sukaiti, N., Al-Tamemi, S. & Shendi, H., Sept 2023, In: Clinical Immunology. 254, 109696.Research output: Contribution to journal › Article › peer-review
3 Link opens in a new tab Citations (Scopus) -
BCG Vaccine-associated Complications in a Large Cohort of Children With Combined Immunodeficiencies Affecting Cellular and Humoral Immunity
Al-Herz, W., Husain, E. H., Adeli, M., Al Farsi, T., Al-Hammadi, S., Al Kuwaiti, A. A., Al-Nesf, M., Al Sukaiti, N., Al-Tamemi, S. & Shendi, H., Nov 1 2022, In: Pediatric Infectious Disease Journal. 41, 11, p. 933-937 5 p.Research output: Contribution to journal › Article › peer-review
8 Link opens in a new tab Citations (Scopus) -
Clinical, immunological, molecular and therapeutic findings in monogenic immune dysregulation diseases: Middle East and North Africa registry
MENA-I. E. I. Study Group, Nov 2022, In: Clinical Immunology. 244, 109131.Research output: Contribution to journal › Article › peer-review
Open Access19 Link opens in a new tab Citations (Scopus) -
Combined Treatment with KV Channel Inhibitor 4-Aminopyridine and either γ-Cystathionine Lyase Inhibitor β-Cyanoalanine or Epinephrine Restores Blood Pressure, and Improves Survival in the Wistar Rat Model of Anaphylactic Shock
Bellou, A., Sennoun, N., Aburawi, E. H., Jayaraj, R. L., Alper, S. L., Alfaki, I. A., Yasin, J., Sekar, S., Shafiuallah, M., Al-Salam, S., Nemmar, A., Kazzam, E., Mertes, P. M. & Al-Hammadi, S., Oct 2022, In: Biology. 11, 10, 1455.Research output: Contribution to journal › Article › peer-review
Open Access3 Link opens in a new tab Citations (Scopus)